Articles published by Johnson & Johnson
   From Johnson & Johnson
   Via Business Wire
   
   
    Johnson & Johnson Reports Q2 2023 Results
    
   July 20, 2023
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   
    Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
    
   May 10, 2023
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   
    Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering
    
   May 03, 2023
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   
    Johnson & Johnson to Participate in the Bernstein 39th Annual Strategic Decisions Conference
    
   April 25, 2023
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   
    Johnson & Johnson Announces Dividend Increase of 5.3%
    
   April 18, 2023
   From Johnson & Johnson
   Via Business Wire
   
   
    Johnson & Johnson Reports Q1 2023 Results
    
   April 18, 2023
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   
    Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature
    
   March 15, 2023
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   
    Johnson & Johnson Announces Pricing of $7.75 Billion of Senior Notes Issued by Kenvue Inc.
    
   March 08, 2023
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   
    Johnson & Johnson Names Paula A. Johnson, President of Wellesley College, to its Board of Directors
    
   February 14, 2023
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   
    Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D
    
   February 13, 2023
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   
    Johnson & Johnson Reports Q4 and Full-Year 2022 Results
    
   January 24, 2023
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   From Johnson & Johnson
   Via Business Wire
   
   
    Johnson & Johnson Completes Acquisition of Abiomed
    
   December 22, 2022
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   
    Johnson & Johnson Announces Extension of Abiomed Tender Offer to December 21, 2022
    
   December 14, 2022
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   
    Johnson & Johnson to Participate in the 41st Annual J.P. Morgan Healthcare Conference
    
   December 07, 2022
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   
    Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board
    
   November 30, 2022
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   
   From Johnson & Johnson
   Via Business Wire
   
   
    Johnson & Johnson Reports Q3 2022 Results
    
   October 18, 2022
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   
    Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference
    
   October 03, 2022
   From Johnson & Johnson
   Via Business Wire
    Tickers
      JNJ
    
   
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.